新冠病毒感染并发溶血性贫血
Hemolytic Anemia Complicating COVID-19 Infection.
作者信息
AbouYabis Abeer N, Bell Grace Thompson
机构信息
Department of Hematology and Oncology, Emory University, Atlanta, GA, USA.
出版信息
J Hematol. 2021 Oct;10(5):221-227. doi: 10.14740/jh906. Epub 2021 Oct 5.
Coronavirus disease 2019 (COVID-19) has been associated with a spectrum of reported hematological complications ranging from immune cytopenias to thromboembolic manifestations of coagulopathy. Moreover, there have been documented cases of hemolytic anemia associated with COVID-19 infection which have been mainly attributed to development of autoantibodies. We report a case of an African-American patient who presented with hemolytic anemia in the second week after his COVID-19 diagnosis. Throughout this report, we explore the potential immune and non-immune etiologies that contributed to the patient's hemolytic anemia in the setting of COVID-19 infection guided by a review of literature.
2019冠状病毒病(COVID-19)与一系列报道的血液学并发症有关,范围从免疫性血细胞减少到凝血病的血栓栓塞表现。此外,已有记录表明COVID-19感染与溶血性贫血有关,这主要归因于自身抗体的产生。我们报告一例非裔美国患者,在其COVID-19诊断后的第二周出现溶血性贫血。在本报告中,我们在文献回顾的指导下,探讨了在COVID-19感染背景下导致该患者溶血性贫血的潜在免疫和非免疫病因。
相似文献
J Hematol. 2021-10
Indian J Pediatr. 2008-5
Clin Psychopharmacol Neurosci. 2018-11-30
TH Open. 2020-8-20
引用本文的文献
Ann Med Surg (Lond). 2023-5-3
Inflammopharmacology. 2022-10
Clin Exp Med. 2023-8
本文引用的文献
BMJ Case Rep. 2020-12-10
Transfusion. 2021-2
Mayo Clin Proc. 2020-8